299 related articles for article (PubMed ID: 17164778)
21. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
Douglas JL; Lin WY; Panis ML; Veres G
Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral vectors for gene therapy of HIV-1 infection.
Mautino MR
Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
[TBL] [Abstract][Full Text] [Related]
23. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.
Bonyhadi ML; Moss K; Voytovich A; Auten J; Kalfoglou C; Plavec I; Forestell S; Su L; Böhnlein E; Kaneshima H
J Virol; 1997 Jun; 71(6):4707-16. PubMed ID: 9151864
[TBL] [Abstract][Full Text] [Related]
24. Transient gene expression by nonintegrating lentiviral vectors.
Nightingale SJ; Hollis RP; Pepper KA; Petersen D; Yu XJ; Yang C; Bahner I; Kohn DB
Mol Ther; 2006 Jun; 13(6):1121-32. PubMed ID: 16556511
[TBL] [Abstract][Full Text] [Related]
25. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E
Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
[TBL] [Abstract][Full Text] [Related]
27. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication.
Davis BM; Humeau L; Dropulic B
Mol Ther; 2004 Feb; 9(2):160-72. PubMed ID: 14759800
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
29. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
[TBL] [Abstract][Full Text] [Related]
30. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
31. Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev.
Mautino MR; Ramsey WJ; Reiser J; Morgan RA
Hum Gene Ther; 2000 Apr; 11(6):895-908. PubMed ID: 10779166
[TBL] [Abstract][Full Text] [Related]
32. Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy.
Grund N; Maier P; Giordano FA; Appelt JU; Zucknick M; Li L; Wenz F; Zeller WJ; Fruehauf S; Allgayer H; Laufs S
Hum Gene Ther; 2010 Aug; 21(8):943-56. PubMed ID: 20210626
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes.
Mautino MR; Morgan RA
AIDS Patient Care STDS; 2002 Jan; 16(1):11-26. PubMed ID: 11839215
[TBL] [Abstract][Full Text] [Related]
35. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.
Zeng L; Planelles V; Sui Z; Gartner S; Maggirwar SB; Dewhurst S; Ye L; Nerurkar VR; Yanagihara R; Lu Y
J Gene Med; 2006 Jan; 8(1):18-28. PubMed ID: 16142830
[TBL] [Abstract][Full Text] [Related]
36. RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.
Stornaiuolo A; Piovani BM; Bossi S; Zucchelli E; Corna S; Salvatori F; Mavilio F; Bordignon C; Rizzardi GP; Bovolenta C
Hum Gene Ther Methods; 2013 Aug; 24(4):228-40. PubMed ID: 23767932
[TBL] [Abstract][Full Text] [Related]
37. Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration.
Griffin DO; Goff SP
Retrovirology; 2016 Mar; 13():14. PubMed ID: 26945863
[TBL] [Abstract][Full Text] [Related]
38. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
39. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
40. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
